Truvestments Capital’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Truvestments Capital’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16	Closed	-$137	–	726
2024 Q1	$137	Hold	16	–	–	﹤0.01%	710
2023 Q4	$56	Hold	16	–	–	﹤0.01%	780
2023 Q3	$57	Hold	16	–	–	﹤0.01%	675
2023 Q2	$93	Hold	16	–	–	﹤0.01%	683
2023 Q1	$601	Hold	16	–	–	﹤0.01%	630
2022 Q4	$474	Hold	16	–	–	﹤0.01%	869
2022 Q3	$1K	Hold	16	–	–	﹤0.01%	613
2022 Q2	$1K	Buy	+16	New	+$619	﹤0.01%	633
2022 Q1	–	Sell	-16	Closed	-$1K	–	585
2021 Q4	$1K	Hold	16	–	–	﹤0.01%	593
2021 Q3	$1K	Hold	16	–	–	﹤0.01%	609
2021 Q2	$2K	Hold	16	–	–	﹤0.01%	565
2021 Q1	$3K	Buy	+16	New	+$3.08K	﹤0.01%	594

Other funds holding TCON

GPFA

Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

Truvestments Capital's TCON Position: Q2 2024 in Review

Truvestments Capital sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 16 shares — an estimated $137 sold.

Truvestments Capital first reported a position in TCON in Q1 2021 and held it in 12 quarters. The position peaked at $3K in Q1 2021. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

Truvestments Capital reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Truvestments Capital sold 16 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $137.
Truvestments Capital first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
Truvestments Capital's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $3K in Q1 2021.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Truvestments Capital's 13F filing for Q2 2024, filed 14 Aug 2024.